Summary. The administration of oestrogen results in increased arterial blood flow in all mammalian species studied to date, but its mechanism of action has not been elucidated. Because an interval of 30\p=n-\60min is observed between oestrogen injection and uterine hyperaemia, it has been suggested that a vasoactive intermediate is involved and recent evidence suggests that catechol oestrogens are the vasoactive oestrogen intermediates.
Introduction
Exposure of rat uterine tissue to exogenous oestrogen results in a marked increase in peroxidase activity (Lucas et ai, 1955; Klebanoff, 1965; Jellinck & Lyttle, 1972; Anderson et ai, 1975; Lyttle & DeSombre, 1977) . Oestrogen-induced peroxidase activity of uterine tissues is mainly associated with subcellular microsomal particles (Lyttle & Jellinck, 1976; Hosoya & Saito, 1981) . However, uterine fluid of oestrogen-primed rats also contains a soluble peroxidase (Klebanoff & Smith, 1970; Hosoya & Saito, 1981) . Others have noted that a portion of eosinophil-stimulated uterine peroxidase activity occurs in the soluble fraction (Lyttle et ai, 1989) . Peroxidases catalyse the conversion of oestrogens to their catechol forms (Jellinck et ai, 1985; Mondschein et ai, 1986; Ball & Knuppen, 1990) . Catechol oestrogens may be mediators of oestrogen-induced uterine hyperaemia (Van Orden et ai, 1986; Ford, 1989; Rosazza et ai, 1989) . Thus, peroxidases may play an important role in the early vascular response to oestrogen.
Although peroxidase is a major oestrogen-regulated secretory protein of uterine epithelium (Jellinck & Newcombe, 1980) , peroxidase activity has never been detected in uterine extracts earlier than 4 h after oestrogen exposure (Lyttle & DeSombre, 1977) . In these reports, guaiacol was used to measure peroxidase activity; the poor sensitivity of this reagent in peroxidase assays probably precluded earlier detection of increased enzyme titres.
The present study uses the much more sensitive, ortho-phenylenediamine assay (Gallati & Brodbeck, 1982) to evaluate peroxidase activities in extracts of uteri taken from immature rats given low doses of oestradiol and to determine whether peroxidase activity is related to the extent of uterine hyperaemia. In addition, we report a substantial quantity of oestrogen-dependent peroxidase activity in the soluble fraction of uterine homogenates. Ortho-phenylenediamine assay of peroxidase activity Peroxidase activity was determined by using the substrates H202 and o-phenylenediamine (Gallati & Brodbeck, 1982 (Fig. 1) . Results are expressed as pg horseradish peroxidase equivalents per mg of uterine tissue wet weight. 
Statistical analyses
Regression analysis was used to determine the dose-response relationship between oestradiol and uterine blood volume and between oestradiol and peroxidase. Analysis of variance was used to test which doses had associated mean responses that differed from one another.
Results
The lowest dose of oestradiol administered (0-5 pg kg-1 body weight) produced a significant (P < 005) increase in uterine blood volume (Fig. 2) ; 1 pg kg-1 body weight produced a greater (P < 005) increase in uterine blood volume than the 0-5 µg kg "' body weight dose but higher doses of oestradiol (up to lOOpg kg^1 body weight) failed to produce any greater increase in uterine blood volume. Uterine blood volume was not altered in animals injected with vehicle (data not shown). Uterine blood volume remained unchanged for 1 h after oestradiol injection and then increased (P < 001) at 2 and 3 h (Fig. 3) .
As was the case for the uterine blood volume responses, the lowest dose of oestradiol that produced a significant (P < 005) increase in uterine peroxidase activity in the Ca2"""-extracted fraction was 0-5 pg kg1 (Fig. 4) . Uterine peroxidase activities at doses of oestradiol from 0-5-5pg kg1 body weight were positively correlated (P < 005, r = 0-79) with the uterine blood volume.
Uterine peroxidase induction was observed during the time course of uterine hyperaemia (Fig. 5 ).
Peroxidase activity (11-5 ± 1-8 pg mg1) was detected in the CaCl2 extract of individual uteri harvested from untreated control animals. Furthermore, oestrogen treatment produced a significant (P < 005) increase in enzyme activity as early as 1 h with no further increase observed at 2 and 3 h. Oestradiol treatment (100 pg kg~' body weight) not only increased the Ca2 +-extracted peroxi¬ dase activity but also increased the level of soluble peroxidase activity (Fig. 6) 
Discussion
Oestrogen administration has previously been shown to increase activity of peroxidase in the uterus considerably with maximal activity appearing 20-24 h after a single injection (DeSombre, 1984) . This study showed for the first time that oestrogen also increases uterine peroxidase activity before this, within 1-3 h after injection. These data also demonstrate that the lowest dose of oestro¬ gen that increases uterine peroxidase (0-5 pg kg-1 body weight) is one-fifth the effective dose reported by others (Lyttle & DeSombre, 1977 The dose-response study showed that uterine peroxidase activity is positively correlated with the early vascular response to oestradiol administration, namely, uterine hyperaemia. It appears that the dose-response range is very narrow 2 h after oestrogen administration when uterine hyperaemia is the dominant oestrogen response. This observation, together with the finding that increases in uterine peroxidase precede increases in uterine blood volume (Figs 3 and 5) , suggests that a change in peroxidase activity is involved in the initiation of uterine vasodilation and that, once underway, enzyme activity does not continue to increase during the hyperaemic response. The biological importance of an early rise in peroxidase activity after oestrogen exposure may be a critical link in the development of uterine hyperaemia. Catechol oestrogens not only dilate the uterine artery in vivo but are also the only oestrogen compounds that are effective in vitro as well (Stice et ai, 1987) . Thus it has been suggested that catechol oestrogens may be the mediators of the vascular effects of oestrogen. We showed that the metabolism of oestrogens by uterine peroxidase yields catechol oestrogens (Rosazza et ai, 1989) and that uterine arteries can synthesize catechol oestrogens from the parent oestrogens (Van Orden et ai, 1983) . In addition, these hydroxylated oestrogens may have a negative feedback effect on peroxidase by behaving like suicide inhibitors of the enzyme that synthesizes them (Rosazza et ai, 1989) . Oestrogen has been reported to inactivate uterine peroxidase; this suggests a role for this enzyme in many diverse events such as cell detoxification, bactericidal action and hormone recycling (Klebanoff, 1965; Brokelman, 1969; Jellinck et ai, 1979) . From previous and present data, a sequence of events after administration of oestrogen may be: increased peroxidase activity, hydroxylation of oestrogen, vasodilation and subsequent inactivation of the synthesizing enzyme, peroxidase.
The origin of the uterine peroxidase that is increased soon after administration of low dose oestrogen is unknown. In studies using long-term exposure to oestrogen ( > 24 h), it has been shown that peroxidase may come from two distinct sources: endogenous uterine tissue peroxidase and eosinophil-derived peroxidase (Tchernitchin eia/., 1974; King et ai, 1981) . Although Olsen & Little ( 1982) suggest that these two enzymes are identical (on the basis of range of similar properties), others have presented cytochemical and biochemical evidence that distinguishes the endogenous and the exogenous or eosinophil peroxidases. Anderson et ai (1986) noted that as many as 15 peroxidase isoforms are expressed at successive stages after stimulation of the uterus with oestrogen.
Since the immature rat has a very poorly developed uterine epithelium, it appears more likely that the peroxidase activity measured very soon after exposure to a low dose of oestrogen could be from eosinophils. Lyttle's group (Lee et al., 1989) has recently proposed that oestrogen regulation of eosinophil peroxidase occurs by a uterine chemotactic factor (ECF-U), the synthesis of which is mediated by the oestradiol receptor. Although they report that the maximum increase was not observed until 24 h, there was a significant increase in ECF-U activity 3 h after injection of 1 pg oestradiol. Peroxidase activity, as measured by the o-phenylenediamine assay in the current study, was significantly increased 1 h after oestrogen injection (Fig. 5) ; this may indicate that the very early response (1-3 h) either precedes the elaboration of the chemotactic protein, or that the detection limits of the chemotaxis assay prevent the measurement of earlier increases in activity. Eosinophils have been shown to increase in number within 5 min of oestrogen administration (Tchernitchin et ai, 1974) but the number of cells required to provide a measurable quantity of peroxidase will depend on the sensitivity of the enzyme assay used.
The administration of oestrogen to immature rats resulted in unexpectedly high peroxidase activity (>200pg mg1 protein) in the soluble fraction of uterine homogenates (Fig. 6) . Others, using the guaiacol assay, have shown little (4-3%) or no activity in the uterine soluble fraction (Hosoya & Saito, 1981) or the hypotonie supernatant fraction (Lyttle & DeSombre, 1977) In conclusion, quantitative measurements of uterine blood volume and uterine peroxidase activity using the sensitive o-phenylenediamine assay provide evidence, for the first time, that levels of peroxidase are directly correlated with the extent of uterine hyperaemia, the early vascular response to exposure to oestrogen. Activity of soluble peroxidase is also high in the uterus during oestrogen hyperaemia and this warrants further study concerning its characteristics and the potential for conversion of oestrogens to vasoactive catechol oestrogen.
